119 related articles for article (PubMed ID: 14767908)
1. [Mutation and amplification of RIT1 gene in hepatocellular carcinoma].
Li JT; Liu W; Kuang ZH; Zhang RH; Chen HK; Feng QS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):43-6. PubMed ID: 14767908
[TBL] [Abstract][Full Text] [Related]
2. [Amplification of RIT1 in hepatocellular carcinoma and its clinical significance].
Li JT; Liu W; Kuang ZH; Chen HK; Li DJ; Feng QS; Liu QC; Hu B
Ai Zheng; 2003 Jul; 22(7):695-9. PubMed ID: 12866958
[TBL] [Abstract][Full Text] [Related]
3. [Overexpression and genomic amplification of decoy receptor 3 in hepatocellular carcinoma and significance thereof].
Shen HW; Wu YL; Peng SY
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):744-7. PubMed ID: 12899749
[TBL] [Abstract][Full Text] [Related]
4. The relationship between point mutation and abnormal expression of c-fms oncogene in hepatocellular carcinoma.
Yang DH; Huang W; Cui J; Shu JC; Tang SH; Zhang WJ; Liang JH
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):86-9. PubMed ID: 14969845
[TBL] [Abstract][Full Text] [Related]
5. bcl 10 gene mutation in hepatocellular carcinoma.
Cheng J; Leng X; Cai S; Cao Z; Cao G; Peng J; Wang S; Du R
Chin Med J (Engl); 2001 Jul; 114(7):747-51. PubMed ID: 11780342
[TBL] [Abstract][Full Text] [Related]
6. [p16 and cyclinD1 protein expression and p16 gene mutation in primary human hepatocellular carcinoma].
Huang GX; Cheng RX; Feng DY
Hunan Yi Ke Da Xue Xue Bao; 2001 Dec; 26(6):527-30. PubMed ID: 12536530
[TBL] [Abstract][Full Text] [Related]
7. Splicing mutations of the p53 gene in human hepatocellular carcinoma.
Lai MY; Chang HC; Li HP; Ku CK; Chen PJ; Sheu JC; Huang GT; Lee PH; Chen DS
Cancer Res; 1993 Apr; 53(7):1653-6. PubMed ID: 8384081
[TBL] [Abstract][Full Text] [Related]
8. [p53 gene mutation in hepatocellular carcinoma].
Jiang W; Lu Q; Pan G
Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):531-2. PubMed ID: 11825456
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.
Mori T; Nomoto S; Koshikawa K; Fujii T; Sakai M; Nishikawa Y; Inoue S; Takeda S; Kaneko T; Nakao A
Liver Int; 2005 Apr; 25(2):380-8. PubMed ID: 15780064
[TBL] [Abstract][Full Text] [Related]
10. Point mutation, allelic loss and increased methylation of c-Ha-ras gene in human hepatocellular carcinoma.
Ogata N; Kamimura T; Asakura H
Hepatology; 1991 Jan; 13(1):31-7. PubMed ID: 1846346
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of the Smad6 and Smad7 genes in hepatocellular carcinoma.
Kawate S; Ohwada S; Hamada K; Koyama T; Takenoshita S; Morishita Y; Hagiwara K
Int J Mol Med; 2001 Jul; 8(1):49-52. PubMed ID: 11408948
[TBL] [Abstract][Full Text] [Related]
12. [Genetic polymorphism of UDP-glucuronosyltransferase 1F and susceptibility to hepatocellular carcinoma].
Liu C; Bian J; Jiang F; Shen F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Aug; 19(4):324-8. PubMed ID: 12170472
[TBL] [Abstract][Full Text] [Related]
13. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
[TBL] [Abstract][Full Text] [Related]
14. Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma.
Takuma Y; Nouso K; Kobayashi Y; Nakamura S; Tanaka H; Matsumoto E; Fujikawa T; Suzuki M; Hanafusa T; Shiratori Y
J Gastroenterol Hepatol; 2004 Nov; 19(11):1300-4. PubMed ID: 15482538
[TBL] [Abstract][Full Text] [Related]
15. Detection of point mutations of BCL10 gene in hepatocellular carcinoma tissues: report of 46 cases.
Jihua C; Xisheng L; Shengli C; Zongxian C; Guang C; Ruyu D
Hum Mutat; 2000 May; 15(5):482-3. PubMed ID: 10790217
[TBL] [Abstract][Full Text] [Related]
16. c-myc amplification in hepatocellular carcinoma predicts unfavorable prognosis.
Abou-Elella A; Gramlich T; Fritsch C; Gansler T
Mod Pathol; 1996 Feb; 9(2):95-8. PubMed ID: 8657726
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray.
Wang Y; Wu MC; Sham JS; Zhang W; Wu WQ; Guan XY
Cancer; 2002 Dec; 95(11):2346-52. PubMed ID: 12436441
[TBL] [Abstract][Full Text] [Related]
18. Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma.
Tamori A; Nishiguchi S; Nishikawa M; Kubo S; Koh N; Hirohashi K; Shiomi S; Inoue M
J Gastroenterol; 2004 Nov; 39(11):1063-8. PubMed ID: 15580399
[TBL] [Abstract][Full Text] [Related]
19. Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma.
Song J; Kim CJ; Cho YG; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
J Gastroenterol Hepatol; 2006 Aug; 21(8):1286-9. PubMed ID: 16872311
[TBL] [Abstract][Full Text] [Related]
20. [Cloning and identification of fibrinogen gamma polypeptide (FGG) gene differentially expressed in human hepatocellular carcinoma].
Fan BL; Zhu WL; Zou GL; Luo GS; Xu CL; Zhao WX
Ai Zheng; 2004 Mar; 23(3):249-53. PubMed ID: 15025951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
